Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.10%
March 31, 2026 -16.92%
December 31, 2025 12.83%
September 30, 2025 21.00%
June 30, 2025 22.30%
March 31, 2025 7.33%
December 31, 2024 33.89%
September 30, 2024 24.54%
June 30, 2024 23.72%
March 31, 2024 11.12%
December 31, 2023 42.53%
September 30, 2023 12.54%
June 30, 2023 38.40%
March 31, 2023 -4.19%
December 31, 2022 5.64%
September 30, 2022 -25.35%
June 30, 2022 -10.91%
March 31, 2022 -12.89%
December 31, 2021 0.27%
September 30, 2021 -9.86%
June 30, 2021 0.78%
March 31, 2021 -8.92%
December 31, 2020 -15.23%
September 30, 2020 -0.05%
June 30, 2020 -11.89%
Date Value
March 31, 2020 -15.70%
December 31, 2019 -1.30%
September 30, 2019 -20.72%
June 30, 2019 -15.00%
March 31, 2019 -43.21%
December 31, 2018 -3.08%
September 30, 2018 -13.85%
June 30, 2018 -10.72%
March 31, 2018 -27.76%
December 31, 2017 -3.55%
September 30, 2017 -16.69%
June 30, 2017 -19.65%
March 31, 2017 -35.92%
December 31, 2016 -9.90%
September 30, 2016 -34.78%
June 30, 2016 -24.18%
March 31, 2016 -49.39%
December 31, 2015 -42.54%
September 30, 2015 -53.07%
June 30, 2015 -30.46%
March 31, 2015 -19.02%
December 31, 2014 17.42%
September 30, 2014 -24.97%
June 30, 2014 2.43%
March 31, 2014 -18.70%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Amarin Corp. Plc -18.12%
Prothena Corp. Plc -1.84K%
Biogen, Inc. 3.72%
Exelixis, Inc. 33.73%
Incyte Corp. 34.98%